Dose Dependency of Pharmacokinetics and Therapeutic Efficacy of Pegylated Liposomal Doxorubicin (DOXIL) in Murine Models.

MLA

Gabizon, Alberto, et al. “Dose Dependency of Pharmacokinetics and Therapeutic Efficacy of Pegylated Liposomal Doxorubicin (DOXIL) in Murine Models.” Journal of Drug Targeting, vol. 10, no. 7, Oct. 2002, pp. 539–48. EBSCOhost, https://doi.org/10.1080/1061186021000072447.

APA

Gabizon, A., Tzemach, D., Mak, L., Bronstein, M., & Horowitz, A. T. (2002). Dose Dependency of Pharmacokinetics and Therapeutic Efficacy of Pegylated Liposomal Doxorubicin (DOXIL) in Murine Models. Journal of Drug Targeting, 10(7), 539–548. https://doi.org/10.1080/1061186021000072447

Chicago

Gabizon, Alberto, Dinah Tzemach, Lidia Mak, Moshe Bronstein, and Aviva T. Horowitz. 2002. “Dose Dependency of Pharmacokinetics and Therapeutic Efficacy of Pegylated Liposomal Doxorubicin (DOXIL) in Murine Models.” Journal of Drug Targeting 10 (7): 539–48. doi:10.1080/1061186021000072447.